Evidence map›Paper›PMID 38904297›Full record

ArticleTherapeutic advances in respiratory disease

Identification and

Amin Hosseini Nami, Mahboubeh Kabiri, Fatemeh Zafarghandi Motlagh, Tina Shirzadeh, Hamideh Bagherian, Razie Zeinali, Ali Karimi, Sirous Zeinali

Abstract readCase Reports
In one paragraph

Article in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amin Hosseini NamiDepartment of Biotechnology, College of Science, University of Tehran, Tehran, Iran.ORCID 0000-0002-4819-6175
Mahboubeh KabiriDepartment of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
Fatemeh Zafarghandi MotlaghDr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center (KHGRC), Tehran, Iran.
Tina ShirzadehDr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center (KHGRC), Tehran, Iran.
Hamideh BagherianDr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center (KHGRC), Tehran, Iran.
Razie ZeinaliDr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center (KHGRC), Tehran, Iran.
Ali KarimiMax Planck Institute for Brain Research, Frankfurt am Main, Germany.
Sirous ZeinaliDr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center (KHGRC), No. 41, Irna St., Valiasr St., Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is an autosomal recessive disease caused by the inheritance of two mutant cystic fibrosis transmembrane conductance regulator (CFTR) alleles, one from each parent. Autosomal recessive disorders are rarely associated with germline mutations or mosaicism. Here, we propose a case of paternal germline mutation causing CF. The subject also had an identifiable maternal mutant allele. We identified the compound heterozygous variants in the proband through Sanger sequencing, and

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorMicrosatellite RepeatsChild, PreschoolComputer SimulationDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseGerm-Line MutationHumansInfantIranMalePhenotypeCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulatorautosomal recessive disordercase reportCFTR mutationcystic fibrosisgenetic counselingmicrosatellite markerpediatric diagnosispulmonary disease

Identifiers

PMID38904297
PMCPMC11193346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.